Advanced Medical Solutions testing surgical superglue stick
A medical superglue developed by Advanced Medical Solutions (AMS) for surgeons to use in operations instead of sutures or staples could be on the market for the first time as early as next year (The Telegraph, 2017). The AIM listed, Cheshire-based maker of wound dressings and surgical equipment, developed the glue, called Liquiband Fix8, at … Continue reading Advanced Medical Solutions testing surgical superglue stick
Frontier Medical announces Canadian distribution deal
Frontier Medical Group has announced a major new distribution contract with Joerns Healthcare in Canada (MediWales, 2017). Under the new deal, Frontier will distribute its Repose range of pressure injury prevention products through Joerns Healthcare in Canada. Joerns Healthcare is one of North America’s leading providers of acute and post-acute health care products and services … Continue reading Frontier Medical announces Canadian distribution deal
New test reaffirms performance criteria for EKF’s Quo-Test
EKF Diagnostics has announced that in a newly published paper its Quo-Test point-of-care haemoglobin A1c (HbA1c) analyser has again been confirmed to meet International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) performance criteria (EKF Diagnostics, 2017). Using sigma-metrics data modelling, scientists from the European Reference Laboratory for Glycohemoglobin demonstrated that Quo-Test easily met IFCC … Continue reading New test reaffirms performance criteria for EKF’s Quo-Test
Brain imaging identifies different types of depression
Biological markers could enable tailored therapies that target individual differences in the symptoms of depression (Scientific American, 2017). New research, published in Nature Medicine, by Conor Liston, a neuroscientist and psychiatrist at Weill Cornell Medical College, and his colleagues seems to point toward a long-sought goal in psychiatry, biological markers to distinguish different kinds of … Continue reading Brain imaging identifies different types of depression
B vitamins reduce schizophrenia symptoms
A review of worldwide studies has found that add-on treatment with high dose B vitamins, including B6, B8 and B12, can significantly reduce symptoms of schizophrenia more than standard treatments alone (University of Manchester, 2017). The research, on the effect of vitamin and mineral supplements on symptoms of schizophrenia, is funded by the MRC and … Continue reading B vitamins reduce schizophrenia symptoms
Research undertaken to discover genetic cause of epilepsy
The University of Liverpool has received a £390,000 grant from the MRC to conduct research into how mutations in genes can cause epilepsy (University of Liverpool, 2017) . Epilepsy is estimated to affect more than 500,000 people in the UK. This means that around one in every hundred people has the condition. Cells in the … Continue reading Research undertaken to discover genetic cause of epilepsy
New nano approach could cut dose of leading HIV treatment in half
Successful results of a trial led by the University of Liverpool which utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress (University of Liverpool, 2017). The healthy volunteer trial, conducted … Continue reading New nano approach could cut dose of leading HIV treatment in half
Cardiff University’s new way of making drug compounds
Researchers at Cardiff University have developed a new “highly-efficient” method of making disease-fighting compounds, including for an anti-malaria drug (BBC News, 2017). Sesquiterpenes can be found in spicy foods, plants and beer, and are used to battle colds, cancer and malaria. A Cardiff University team said it could synthesise them more quickly and cost-effectively than … Continue reading Cardiff University’s new way of making drug compounds
Cardiff University are coordinating a new cancer study
The first patient has been successfully recruited into an important new cancer study being co-ordinated by a team of experts at Cardiff University (Cardiff University, 2017). The trial could have profound ramifications for treatment of an uncommon form of cancer that affects the elderly, who cannot tolerate aggressive chemotherapy treatments. MONOCLE is a Phase II … Continue reading Cardiff University are coordinating a new cancer study
Research aims to reduce premature deaths in young people
BHF Cymru are investing £2.3m in research at Swansea University to help reduce the number of premature deaths in young people (Swansea University, 2017). It is estimated that one person every fortnight aged under thirty five in Wales is a victim of sudden cardiac death with seemingly no explanation, largely due to undiagnosed inherited heart … Continue reading Research aims to reduce premature deaths in young people
